Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessZscaler’s Upcoming Q3 Earnings Preview

Zscaler’s Upcoming Q3 Earnings Preview

Add to Favorite
Added to Favorite


RBC Capital analysts provided their outlook on Zscaler (NASDAQ:ZS) ahead of the Q3/23 earnings, scheduled to be announced today after the market close.
In early May, the company announced positive preliminary Q3 results noting they expect to come in above the high-end of guidance for both the top-line and profitability with a key being billings acceleration from Q2. Specifically, management increased its 2023 revenue/billings guidance by $28.5 million/$32 million, or more/in line with the preliminary Q3 midpoint beat of $20 million/$31 million, respectively.
As such, the focus remains on the competitive landscape, macros, and the ability to consolidate security spend and any thoughts on 2024 expectations. The analysts reiterated their Outperform rating and $155 price target.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Canaan Inc. Gears Up for Earnings Amid Challenges

Projected earnings per share (EPS) of -$0.6 and revenue...

cbdMD, Inc. Q2 Fiscal Year 2024 Financial Results Overview

Significant revenue achievement: cbdMD reported revenue of approximately $4.38...

Ascendis Pharma Faces FDA Review Extension: Insights and Market Impact

The FDA has extended its review period for Ascendis...

Nordson Corporation Quarterly Earnings Preview

Wall Street anticipates an EPS of $2.30 and revenue...